ANIK FY 2020 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$208M

FY 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$130M+13.8% YoY

Gross Profit

$69M52.9% margin

Operating Income

-$28M-21.7% margin

Net Income

-$24M-18.4% margin

EPS (Diluted)

$-1.69

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$11M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$366M

Total Liabilities

$93M

Stockholders' Equity

$272M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$130M	$115M	+13.8%
Gross Profit	$69M	$86M	-19.6%
Operating Income	-$28M	$34M	-182.7%
Net Income	-$24M	$27M	-188.2%